DAUNORUBICIN + CYTARABINE

DAUNORUBICIN + CYTARABINE (14661P)

daunorubicin hydrochloride 44 mg + cytarabine 100 mg injection, 1 vial
14661P
Body System:
Manner of administration:Injection
Public
Chemotherapy Items for Public Hospital use
Authority Required

Restriction

Indication: Acute Myeloid Leukaemia
Treatment phase: Consolidation therapy
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 64 mg # of repeats: 3 DPMA: $16,521.23 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Vyxeos
(daunorubicin hydrochloride 44 mg + cytarabine 100 mg injection, 1 vial)

DAUNORUBICIN + CYTARABINE (14663R)

daunorubicin hydrochloride 44 mg + cytarabine 100 mg injection, 1 vial
14663R
Body System:
Manner of administration:Injection
Private
Chemotherapy Items for Private Hospital use
Authority Required

Restriction

Indication: Acute Myeloid Leukaemia
Treatment phase: Induction therapy
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 97 mg # of repeats: 4 DPMA: $25,126.93 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Vyxeos
(daunorubicin hydrochloride 44 mg + cytarabine 100 mg injection, 1 vial)

DAUNORUBICIN + CYTARABINE (14669C)

daunorubicin hydrochloride 44 mg + cytarabine 100 mg injection, 1 vial
14669C
Body System:
Manner of administration:Injection
Public
Chemotherapy Items for Public Hospital use
Authority Required

Restriction

Indication: Acute Myeloid Leukaemia
Treatment phase: Induction therapy
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 97 mg # of repeats: 4 DPMA: $24,736.23 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Vyxeos
(daunorubicin hydrochloride 44 mg + cytarabine 100 mg injection, 1 vial)

DAUNORUBICIN + CYTARABINE (14672F)

daunorubicin hydrochloride 44 mg + cytarabine 100 mg injection, 1 vial
14672F
Body System:
Manner of administration:Injection
Private
Chemotherapy Items for Private Hospital use
Authority Required

Restriction

Indication: Acute Myeloid Leukaemia
Treatment phase: Consolidation therapy
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 64 mg # of repeats: 3 DPMA: $16,796.92 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Vyxeos
(daunorubicin hydrochloride 44 mg + cytarabine 100 mg injection, 1 vial)